Sherrer v. Hale, 38037

Decision Date07 January 1982
Docket NumberNo. 38037,38037
Citation248 Ga. 793,285 S.E.2d 714
PartiesWebster A. SHERRER et al. v. Henry A. HALE et al.
CourtGeorgia Supreme Court

John M. Comolli and Dennis S. Mackin, Cohen, Mackin, Pollock, Cooper & Comolli, Atlanta, for Webster A. Sherrer et al.

Archer D. Smith, III, Atlanta, for Henry A. Hale et al.

HILL, Presiding Justice.

This is an appeal from the trial court's grant of an interlocutory injunction, ordering the reversion of Pathology Associates of Marietta, P. C., into a traditional business corporation and the reinstatement of Mr Henry Hale's shareholder interest in that corporation.

Pathology Associates of Marietta, P. C. [hereinafter PAM, P. C.], was incorporated as a professional corporation under Code Ch. 84-54 in 1972 by Dr. Webster A. Sherrer, a licensed physician and specialist in pathology, who acquired all 100 shares of the corporation's stock. The corporation operated a licensed clinical laboratory under the supervision of Dr. Sherrer which performed various tests and microscopic examinations on human tissue and specimens submitted by area physicians. 1 The results of the tests or examinations, and sometimes diagnoses and recommendations, were then made by Dr. Sherrer to the submitting physician.

Due in part to financial difficulties experienced by the company, in May of 1976 Dr. Sherrer amended the articles of incorporation and converted the business from a professional corporation into a traditional business corporation, Pathology Associates of Marietta, Inc. [PAM, Inc.], in order to permit his business advisor, Mr. Henry Hale, a nonphysician, to become a shareholder. 2 Mr. Hale purchased 50 shares of stock from Dr. Sherrer for $3332.00 (one-half of the corporation's book value) and received a bill of sale for the stock. Neither Dr. Sherrer nor Mr. Hale received stock certificates and neither interest was listed in the corporation's stock records. A shareholder's agreement was executed which empowered Dr. Sherrer to unilaterally repurchase Mr. Hale's stock at any time within four years by paying Mr. Hale one-half of the corporation's book value. Dr. Sherrer was elected president of the corporation and Mr. Hale was elected a director and the corporation's secretary.

Contemporaneous with the conversion of the professional corporation into a business corporation, Dr. Sherrer incorporated a professional corporation in Dalton, Georgia, for tax and pension advantages. Dr. Sherrer then moved to Dalton, executed an exclusive employment agreement with his Dalton corporation and accepted a position with a local hospital. All compensation earned by Dr. Sherrer from the hospital and PAM, Inc., was paid to his Dalton corporation.

In Dr. Sherrer's absence, Mr. Hale assumed the marketing and management responsibilities for PAM, Inc., and Dr. Louis Rodriguez, M. D., was retained to replace Dr. Sherrer in the Marietta laboratory. Dr. Rodriguez continued the practice of sometimes issuing to requesting physicians diagnoses and recommendations based on the laboratory findings. It is unclear whether Dr. Rodriguez was performing as an employee of the corporation or an independent contractor, although the evidence does show that PAM, Inc., had medical malpractice insurance, diagnoses were issued on corporate stationary, and the corporation billed and collected the fees for Dr. Rodriguez's services.

In 1979, Dr. Sherrer left Dalton, returned to Marietta and replaced Dr. Rodriguez at PAM, Inc., continuing to be paid only through his Dalton professional corporation. Although discussions were held between Dr. Sherrer and Mr. Hale concerning the repurchase of Mr. Hale's stock by Dr. Sherrer, Dr. Sherrer's unilateral repurchase rights contained in the shareholder's agreement expired without being exercised.

In January, 1981, Dr. Sherrer retained counsel to assist him in negotiating the repurchase of Mr. Hale's stock. His attorney informed him that, by issuing diagnoses, PAM, Inc., was engaged in the practice of medicine and that a corporation could practice medicine only in the form of a professional corporation. Thus, according to the attorney, the conversion of the company in 1976 into a business corporation was void and it remained a professional corporation. Furthermore, advised the attorney, shares in a professional corporation issued or transferred to a person not licensed in the profession being practiced are void. Therefore, according to counsel, Mr. Hale was not legally a shareholder in the corporation.

Acting on this advice, Dr. Sherrer called meetings of the shareholders and directors of PAM, Inc., on February 4, 1981, without giving Mr. Hale notice. At those meetings, Dr. Sherrer declared Mr. Hale's shareholder's interest void and removed him as secretary of the corporation. On February 5, Dr. Sherrer filed an amendment to the articles of incorporation converting the company back into a professional corporation. Mr. Hale received notice of these actions in a letter from Dr. Sherrer's attorney dated February 6, 1981. Mr. Hale has received no refund or other compensation for his interest in the corporation.

Mr. Hale then filed suit, individually and as a shareholder's derivative action, against Dr. Sherrer and PAM, P. C., seeking, inter alia, an injunction prohibiting interference with his status as a shareholder, director and officer of the corporation. After a hearing, the trial court ruled that equitable relief was necessary to prevent irreparable harm to Mr. Hale and issued an interlocutory injunction declaring Dr. Sherrer's actions at the corporate meetings of February 4, 1981, void and ordering the reversion of PAM, P. C., into a business corporation. Dr. Sherrer appeals the granting of the temporary injunction.

Dr. Sherrer contends that, under the statutory definition of "clinical laboratory", Code Ann. § 84-5502(d), 3 there are two different types of clinical laboratories in operation. Some, according to Dr. Sherrer, are "assay" laboratories which merely conduct tests and examinations and report the results back to the requesting physician. Others, "diagnostic" laboratories (such as the Marietta laboratory here in issue), make diagnoses and recommendations which are then given to the requesting physician. Dr. Sherrer argues that although "assay" laboratories (which do not engage in the practice of medicine) may be owned by nonphysicians and may be operated as business corporations, "diagnostic" laboratories (which by statutory definition, Code Ann. § 84-901, 4 do engage in the practice of medicine) may only be owned by physicians and may only be operated as professional corporations. [Quare: Does a laboratory which makes diagnoses and recommendations to requesting physicians hold itself out "to the public" within the meaning of Code Ann. § 84-901?] Mr. Hale argues, inter alia, that because at least thirteen clinical laboratories with nonphysician shareholders are licensed by the Department of Human Resources, nonphysician ownership of clinical laboratories engaged in the practice of medicine is authorized by the Clinical Laboratory Act, Code Ch. 84-55. We find it both unnecessary and inappropriate to rule on this issue in this case.

Dr. Sherrer also argues that because Mr. Hale has an adequate remedy at law (money damages), injunctive (equitable) relief was not authorized. As is often the case, in order to determine whether equitable relief is authorized, we must first ascertain what rights, if any, the plaintiff has which warrant protection. Thus, we defer this question until after consideration of the merits.

1. Dr. Sherrer urges that since their inception PAM, P. C., and PAM, Inc., have been engaged in the...

To continue reading

Request your trial
27 cases
  • De Fontaine v. Passalino
    • United States
    • United States Appellate Court of Illinois
    • December 24, 1991
    ...The corporation was ordered to pay the plaintiff's attorney fees for securing the judgment for the corporation. Sherrer v. Hale (1982), 248 Ga. 793, 285 S.E.2d 714, also supports plaintiff's position that attorney fees can be awarded where there are two Defendant contends that there are no ......
  • Vann v. DeKalb County Bd. of Tax Assessors
    • United States
    • United States Court of Appeals (Georgia)
    • January 20, 1988
    ...to the ends of justice and its prompt administration as the remedy in equity, it will exclude appropriate equity relief. Sherrer v. Hale, 248 Ga. 793(2), 285 S.E.2d 714; Middlebrooks v. Lonas, 246 Ga. 720(2), 272 S.E.2d 687, citing Atlantic Coast Line R. Co. v. Gunn, 185 Ga. 108, 194 S.E. 3......
  • Health Horizons v. STATE FARM MUT. AUTO.
    • United States
    • United States Court of Appeals (Georgia)
    • July 29, 1999
    ...is not practicing medicine under such limited circumstances. See OCGA §§ 14-7-3; 14-7-4; 43-34-26(a); 43-34-43; Sherrer v. Hale, 248 Ga. 793, 796, 285 S.E.2d 714 (1982); Pearle Optical &c. v. State Bd. of Examiners in Optometry, 219 Ga. 364, 133 S.E.2d 374 Sherrer v. Hale, supra at 796, 285......
  • Mitchum v. State
    • United States
    • Supreme Court of Georgia
    • October 7, 2019
    ...to the ends of justice and its prompt administration as the remedy in equity." (Citation and punctuation omitted.) Sherrer v. Hale , 248 Ga. 793, 797-798 (2), 285 S.E.2d 714 (1982). Furthermore, OCGA § 9-14-42 (c) (4) provides that the statute of limitations is tolled until "[t]he date on w......
  • Request a trial to view additional results
1 books & journal articles
  • Variations on a Theme: Georgia's Evolving Test for Interlocutory Injunctive Relief
    • United States
    • State Bar of Georgia Georgia Bar Journal No. 28-1, August 2022
    • Invalid date
    ...Southern Healthcare Systems v. Health Care Capital Consolidated, 273 Ga. 834, 835, 545 S.E.2d 882, 885 (2001), citing Sherrer v. Hale, 248 Ga. 793, 797, 285 S.E.2d 714, 718 (1982). See also O.C.G.A. § 23-1-4 (2020). [13] In some jurisdictions, the terms "irreparable injury" and "inadequate ......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT